5 insiders reported 6 Form 4 transactions for BRAINSTORM CELL THERAPEUTICS INC. (BCLI) over the past 18 months (most recent 2026-07-28). Recent activity: FRENKEL JACOB A (Director) Buy 100,000 shares, FRENKEL JACOB A (Director) Buy 200,000 shares, ARBEL IRIT (Director) Buy 120,000 shares, Lebovits Chaim (President & CEO) Buy 1.8M shares, Yablonka Uri (EVP & Chief Business Officer) Buy 150,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-28 | FRENKEL JACOB A | Director | Buy | 100,000 | $0 |
| 2026-05-29 | FRENKEL JACOB A | Director | Buy | 200,000 | $0 |
| 2026-05-29 | ARBEL IRIT | Director | Buy | 120,000 | $0 |
| 2026-05-29 | Lebovits Chaim | President & CEO | Buy | 1.8M | $0 |
| 2026-05-29 | Yablonka Uri | EVP & Chief Business Officer | Buy | 150,000 | $0 |
| 2026-05-29 | Patlis Alla | See Remarks | Buy | 100,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-28